In contrast, reducing miR-34a levels in obese mice restores Nampt and NAD levels and improves inflammation, glucose intolerance, and hepatic steatosis through the Nampt-NAD-SIRT1 axis [96]. Here, NAMPT is linked to Glucose intolerance.